Facet replacement: The new motion treatment paradigm for spinal stenosis and spondylolisthesis patients
The TOPS System was first implanted in 2005 and the current version has been in clinical use for a dozen years. As of today, thousands of patients have benefited from this innovative system.
This white paper examines how the TOPS System provides an entirely new modality to treat patients with spinal stenosis and spondylolisthesis. TOPS is the first and only FDA-approved facet replacement device with a superiority-to-fusion claim.
A disruptive breakthrough in spinal care, TOPS uniquely addresses the needs of patients, surgeons, facilities and payers to create a broad win for all stakeholders.
Key takeaways about TOPS:
This white paper examines how the TOPS System provides an entirely new modality to treat patients with spinal stenosis and spondylolisthesis. TOPS is the first and only FDA-approved facet replacement device with a superiority-to-fusion claim.
A disruptive breakthrough in spinal care, TOPS uniquely addresses the needs of patients, surgeons, facilities and payers to create a broad win for all stakeholders.
Key takeaways about TOPS:
- Motion alternative to lumbar spinal fusion
- FDA labeled as superior to spinal fusion
- New Technology Add-on Payment of up to $11,375 for Medicare eligible procedures
Please fill out the form to download the whitepaper.